In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Scholar Rock Holding Corp’s stock clocked out at $42.86, down -5.11% from its previous closing price of $45.17. In other words, the price has decreased by -$5.11 from its previous closing price. On the day, 0.97 million shares were traded. SRRK stock price reached its highest trading level at $46.13 during the session, while it also had its lowest trading level at $42.615.
Ratios:
To gain a deeper understanding of SRRK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 26, 2024, Reiterated its Buy rating but revised its target price to $50 from $40 previously.
On October 07, 2024, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $30 to $35.
On March 28, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $30.Raymond James initiated its Strong Buy rating on March 28, 2024, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 10 ’24 when Invus Public Equities, L.P. sold 1,600,000 shares for $41.65 per share. The transaction valued at 66,640,000 led to the insider holds 9,250,005 shares of the business.
Invus Public Equities, L.P. sold 409,433 shares of SRRK for $15,757,639 on Nov 25 ’24. The 10% Owner now owns 10,850,005 shares after completing the transaction at $38.49 per share. On Nov 25 ’24, another insider, Marantz Jing L., who serves as the CHIEF MEDICAL OFFICER of the company, sold 6,375 shares for $39.44 each. As a result, the insider received 251,399 and left with 72,855 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRRK now has a Market Capitalization of 4012338944 and an Enterprise Value of 3939877888.
Stock Price History:
The Beta on a monthly basis for SRRK is 0.52, which has changed by 1.7796924 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, SRRK has reached a high of $46.19, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 18.41%, while the 200-Day Moving Average is calculated to be 135.09%.
Shares Statistics:
It appears that SRRK traded 2.07M shares on average per day over the past three months and 1012480 shares per day over the past ten days. A total of 80.08M shares are outstanding, with a floating share count of 71.51M. Insiders hold about 23.62% of the company’s shares, while institutions hold 71.66% stake in the company. Shares short for SRRK as of 1734048000 were 15072375 with a Short Ratio of 7.28, compared to 1731628800 on 15144673. Therefore, it implies a Short% of Shares Outstanding of 15072375 and a Short% of Float of 29.799998.
